2025 Longitudinal Assessment References

2025 Longitudinal Assessment References

Due to copyright restrictions, the AOBNP cannot provide most reference materials used for longitudinal assessment. However, a list of references used for the 2025 longitudinal assessment can be found below. A hyperlink to PubMed for each article is provided.

Psychiatry

• Carlat Psychiatry Report (Sep 2023); Vol. 21, Issue 9; A disease-modifying approach to mood conditions; pg. 1-6. https://www.thecarlatreport.com/articles/4477-a-disease-modifying-approach-to-mood-conditions
• Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), 5th ed. (2022); Section 2: Somatic Symptom and Related Disorders. https://www.psychiatry.org/psychiatrists/practice/dsm
• Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR), 5th ed. (2022); Trauma- and Stressor-Related Disorders. https://www.psychiatry.org/psychiatrists/practice/dsm
• Drugs & Aging (Sep 2020); Vol. 37, Issue 10; Drug-related orthostatic hypotension: Beyond anti-hypertensive medications; pg. 725-738. https://pubmed.ncbi.nlm.nih.gov/32894454/
• DSM-5 Self-Exam Questions: Test Questions for the Diagnostic Criteria (2014); pg. 166-169
• Gabbard’s Textbook of Psychotherapeutic Treatments, 2nd ed. (2023); Ch. 11: Treatment Techniques in Dialectical Behavior Therapy
• General Hospital Handbook of General Hospital Psychiatry, 6th ed. (2010); Ch. 21: Catatonia, Neuroleptic Malignant Syndrome, and Serotonin Syndrome; pg. 273–277
• Healthy Children (Updated Mar 2023); Complementary & alternative therapies for autism. https://www.healthychildren.org/English/health-issues/conditions/Autism/Pages/complementary-and-alternative-therapies-for-autism-what-parents-need-to-know.aspx
• International Journal of Bipolar Disorders (Jul 2015); Vol. 3; The suicide prevention effect of lithium: More than 20 years of evidence – a narrative review; pg. 15. https://pubmed.ncbi.nlm.nih.gov/26183461/
• Intervening Early in Psychosis: A Team Approach, 1st ed. (2019); Ch. 13: Psychotherapeutic Interventions for Early Psychosis; pg. 211-237
• Kaplan & Sadock’s Synopsis of Psychiatry, 11th ed. (2015):
  • Ch. 13
  • Ch. 25
  • Ch. 34
  • Ch. 36
  • Ch. 37
  • Ch. 59
  • pg. 1066-1067
• Kaplan & Sadock’s Synopsis of Psychiatry, 12th ed. (2021):
  • Ch. 2; Complementary and Alternative Medicine (CAM) Approaches to Autism Spectrum Disorder
  • Ch. 4.6: Stimulant-Related Disorders
  • Ch. 4.9: Hallucinogen-Related Disorders
  • Ch. 12
  • Ch. 21.3: Mood Stabilizers; Lithium
  • Ch. 27
  • Ch. 28
  • pg. 338
  • pg. 486
  • pg. 735-738
• Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 7th ed. (2017):
  • 34.14
  • 34.7
• Kaufman’s Clinical Neurology for Psychiatrists, 8th ed. (2016):
  • 12: Visual Disturbances; pg. 264
  • 17; pg. 367
  • 18: Involuntary Movement Disorder
  • 20: Lumbar Puncture and Imaging Studies
• Osteopathic Family Physician (May-Jun 2017); Vol. 9, Issue 3; Effectiveness of a clinically oriented motivational interviewing training program in increasing skills & changing perspectives; pg. 10-17. https://www.acofp.org/docs/default-source/ofp/vol-9-no-3-(2017)-may-june-2017/effectiveness-of-a-clinically-oriented-motivational-interviewing-training-program-in-increasing-skills-changing-perceptions.pdf?sfvrsn=bc219160_0
• Psychosomatics (Sep-Oct 2020); Vol. 61, Issue 5; Complementary medicine and natural medications in psychiatry: A guide for the consultation-liaison psychiatrist; pg. 508-517. https://pubmed.ncbi.nlm.nih.gov/32460988/
• Seizure (Dec 2022); Vol. 22; Levetiracetam induces severe psychiatric symptoms in people with epilepsy; pg. S1059-S1311. https://pubmed.ncbi.nlm.nih.gov/36535885/
• Stahl’s Essential Psychopharmacology, 5th ed. (2021); pg. 439-440
• The American Psychiatric Association Publishing Textbook of Psychopharmacology, 5th ed. (2017); Ch. 36: Lithium
• The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, 3rd ed. (2019); Ch. 13: Eating Disorders
• Translational Psychiatry (Jul 2022); Vol. 12, Issue 1; Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: A systematic review and network meta-analysis. https://pubmed.ncbi.nlm.nih.gov/35790713/

Neurology

• Adams and Victor’s Principles of Neurology, 11th ed. (2019); Ch. 46; pg. 1470
• Advances in Therapy (Mar 2022); Vol. 39, Issue 5; Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: A network meta-analysis; pg. 1993-2008. https://pubmed.ncbi.nlm.nih.gov/35247186/
• Aging (Jul 2020); Vol. 12, Issue 14; Cortical atrophy mediates the accumulating effects of vascular risk factors on cognitive decline in the Alzheimer’s disease spectrum; pg. 15058-15076. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425455/
• Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association (Nov 2018); Vol. 14, Issue 11; Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease; pg. 1505-1521. https://pubmed.ncbi.nlm.nih.gov/30316776/
• American Journal of Neuroradiology (Aug 2007); Vol. 28, Issue 7; Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome; pg. 1320-1327. https://pubmed.ncbi.nlm.nih.gov/17698535/
• CNS Drugs (Jun 2021); Vol. 35, Issue 6; Pharmacology of cenobamate: Mechanism of action, pharmacokinetics, drug-drug interactions and tolerability; pg. 609-618. https://pubmed.ncbi.nlm.nih.gov/33993416/
• Continuum (Jun 2015); Vol. 21, Issue 3; Functional neurologic disorders; pg. 818-837. https://pubmed.ncbi.nlm.nih.gov/26039857/
• Continuum (Aug 2021); Vol. 27, Issue 4; Neurosyphilis; pg. 1018-1039. https://pubmed.ncbi.nlm.nih.gov/34623102/
• Continuum (Oct 2021); Vol. 27, Issue 5; Moderate and severe traumatic brain injury; pg. 1278-1300. https://pubmed.ncbi.nlm.nih.gov/34618760/
• Continuum (Aug 2022); Vol. 28, Issue 4; Treatment of multiple sclerosis; pg. 1025-1051. https://pubmed.ncbi.nlm.nih.gov/35938656/
• Continuum (Oct 2022); Vol. 28, Issue 5; Surgical therapies for Parkinson disease; pg. 1301-1313. https://pubmed.ncbi.nlm.nih.gov/36222766/
• Continuum (Feb 2024); Vol. 30, Issue 1: https://journals.lww.com/continuum/toc/2024/02000
  • Infections myelopathies; pg. 133-159.
  • Metabolic and toxic myelopathies; pg. 200-201.
  • Metabolic and toxic myopathies; pg. 207-208.
  • Vascular myelopathies; pg. 160-179.
• Continuum: Headache (Apr 2024); Vol. 30, Issue 2: https://journals.lww.com/continuum/toc/2024/04000
  • Acute treatment of migraine; pg. 344-363.
  • Medication-overuse headache; pg. 379-390.
  • Preventive treatment of migraine; pg. 367-378.
• Cureus (Sep 2018); Vol. 10, Issue 9; Differential diagnosis and treatment of restless legs syndrome: A literature review; pg. 3297. https://www.cureus.com/articles/13971-differential-diagnosis-and-treatment-of-restless-legs-syndrome-a-literature-review
• Georgian Medical News (Apr 2021); Vol. 313; Post-traumatic headache. Current views on pathophysiological mechanisms of development and clinical specifics (review); pg. 60-65. https://pubmed.ncbi.nlm.nih.gov/34103432/
• International Journal of Environmental Research and Public Health (Feb 2021); Vol. 18, Issue 4; The hypoglossal nerve stimulation as a novel therapy for treating obstructive sleep apnea-a literature review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914469/
• International Journal of Environmental Research and Public Health (May 2023); Vol. 20, Issue 10; Physical rehabilitation of motor functional neurological disorders: A narrative review. https://pubmed.ncbi.nlm.nih.gov/37239521/
• Journal of Attention Disorders (May 2023); Vol. 27, Issue 7; Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment; pg. 669-697. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173356/
• Journal of the Neurologic Sciences (Nov 2007); Vol. 262, Issue 1-2; Carbon monoxide intoxication: An updated review; pg. 122-130. https://pubmed.ncbi.nlm.nih.gov/17720201/
• Mayo Clinic Proceedings (Jul 2021); Vol. 96, Issue 7; The management of restless legs syndrome: An updated algorithm; pg. 1921-1937. https://pubmed.ncbi.nlm.nih.gov/34218864/
• Medicine (Baltimore) (Oct 2023); Vol. 102, Issue 43; Zavegepant nasal spray for acute treatment of migraine: A meta-analysis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615551/
• Molecular Neurodegeneration (Nov 2022); Vol. 17, Issue 1; ApoE in Alzheimer’s disease; pg. 72. https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-022-00574-4
• Neurology and Therapy (Sep 2022); Vol. 11, Issue 3; Atogepant for the prevention of episodic migraine in adults: A systematic review and meta-analysis of efficacy and safety; pg. 1235-1252. https://pubmed.ncbi.nlm.nih.gov/35705886/
• Neuroradiology, 2nd ed. (2003); Ch. 8; pg. 398
• Polish Journal of Radiology (Feb 2017); Vol. 82; Various imaging manifestations of posterior reversible encephalopathy syndrome (PRES) on magnetic resonance imaging (MRI); pg. 64-70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310227/
• Radiopaedia (Updated May 2024); Thalamic hemorrhage. https://radiopaedia.org/articles/thalamic-haemorrhage-1?lang=us
• Seizure (Aug 2021); Vol. 90; Update on first unprovoked seizure in children and adults: A narrative review; pg. 28-33. https://pubmed.ncbi.nlm.nih.gov/33840584/
• Sleep Neurology (Aug 2023); Vol. 29, No. 4; REM sleep behavior disorder and other REM parasomnias; pg. 1092-1116. https://pubmed.ncbi.nlm.nih.gov/37590824/
• StatPearls (Updated Apr 2023); Syringomyelia. https://www.ncbi.nlm.nih.gov/books/NBK537110/
• Stroke (Jun 1995); Vol. 26, No. 6; Thalamic hemorrhage: A prospective study of 100 patients; pg. 964-970. https://pubmed.ncbi.nlm.nih.gov/7762047/
• The Lancet Neurology (Nov 2018); Vol. 17, Issue 11; Comorbidities, treatment, and pathophysiology in restless legs syndrome; pg. 994-1005. https://pubmed.ncbi.nlm.nih.gov/30244828/
• The New England Journal of Medicine (Sep 2011); Vol. 365, Issue 11; Stenting versus aggressive medical therapy for intracranial arterial stenosis; pg. 993-1003. https://pubmed.ncbi.nlm.nih.gov/21899409/